Learn about Altamira and Divincell's cutting-edge formulation techniques for thermostable mRNA products, which reduce cold chain dependencies and increase global accessibility. Do not pass up the ...

At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new April 4th contracts and identified one put and one call contract of particular interest.

At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new April 11th contracts and identified the following call contract of particular interest.

WHO 13's Zach Fisher reports ...

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...

At a time when global coordination against health threats is critical, recent policy shifts in the U.S. have created a ...

X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural ...

The Trump administration’s efforts to reorient the country away from cutting-edge research will be felt by nearly every area ...

An exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, on 20 April 2021.

In a remarkable showcase of innovation and competitiveness, Anshan's state-owned enterprises have made their mark at the Northeast "Three Provinces and One Region" State-Owned Enterprises "Spark" ...

According to Arizton’s latest research report, the lipid-based pharma excipients market is growing at a CAGR of 5.63% during ...